
LMAT
USDLeMaitre Vascular Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$83.000
Kõrge
$89.010
Madal
$81.570
Maht
0.06M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
2.0B
Tööstusharu
Medical Instruments & Supplies
Riik
United States
Kauplemisstatistika
Keskmine maht
0.17M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 30. okt 2025LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings
Price Action: Volatility and Support Testing
LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:
- Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
- Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
- Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.
Sentiment: Analysts Push Against Market Skepticism
- Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
- Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
- Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).
Predictive Outlook: AI Detects Short-Term Momentum
AI models project a cautious upside over 3 days:
- Day 1: +0.2% (flat move, low confidence)
- Day 2: +2.6% (strongest signal)
- Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.
Strategic Guidance: Play the Range, Watch Debt Shadows
Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.
Seotud uudised
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 10. nov 2025, 10:37
63.1% Kindlus
Risk ja kauplemine
Sisenemispunkt
$86.47
Võta kasum
$88.43
Peata kahjum
$78.02
Põhitegurid
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.